Annual Short Term Debt
$1.04 M
+$140.00 K+15.47%
31 December 2023
Summary:
ADMA Biologics annual short term debt is currently $1.04 million, with the most recent change of +$140.00 thousand (+15.47%) on 31 December 2023. During the last 3 years, it has risen by +$453.90 thousand (+76.79%). ADMA annual short term debt is now -82.90% below its all-time high of $6.11 million, reached on 31 December 2016.ADMA Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$1.19 M
+$51.00 K+4.47%
30 September 2024
Summary:
ADMA Biologics quarterly short term debt is currently $1.19 million, with the most recent change of +$51.00 thousand (+4.47%) on 30 September 2024. Over the past year, it has increased by +$148.00 thousand (+14.16%). ADMA quarterly short term debt is now -82.15% below its all-time high of $6.68 million, reached on 31 March 2017.ADMA Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADMA Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +14.2% |
| 3 y3 years | +76.8% | +101.8% |
| 5 y5 years | +356.1% | +420.7% |
ADMA Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +76.8% | at high | +105.8% |
| 5 y | 5 years | at high | +356.1% | at high | +515.0% |
| alltime | all time | -82.9% | -82.2% |
ADMA Biologics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.19 M(+4.5%) |
| June 2024 | - | $1.14 M(+4.5%) |
| Mar 2024 | - | $1.09 M(+4.6%) |
| Dec 2023 | $1.04 M(+15.5%) | $1.04 M(+6.3%) |
| Sept 2023 | - | $982.90 K(+0.3%) |
| June 2023 | - | $979.50 K(+2.5%) |
| Mar 2023 | - | $956.00 K(+5.6%) |
| Dec 2022 | $905.00 K(+53.1%) | $905.00 K(+25.6%) |
| Sept 2022 | - | $720.80 K(+24.3%) |
| June 2022 | - | $579.70 K(-11.4%) |
| Mar 2022 | - | $654.00 K(+10.6%) |
| Dec 2021 | $591.10 K(+61.6%) | $591.10 K(+17.9%) |
| Sept 2021 | - | $501.20 K(+29.9%) |
| June 2021 | - | $385.90 K(+21.4%) |
| Mar 2021 | - | $317.90 K(-13.1%) |
| Dec 2020 | $365.70 K(+59.6%) | $365.70 K(+32.5%) |
| Sept 2020 | - | $276.00 K(+30.9%) |
| June 2020 | - | $210.90 K(+8.7%) |
| Mar 2020 | - | $194.00 K(-15.3%) |
| Dec 2019 | $229.10 K(+663.7%) | $229.10 K(-0.2%) |
| Sept 2019 | - | $229.50 K(+2.9%) |
| June 2019 | - | $223.10 K(+6.5%) |
| Mar 2019 | - | $209.50 K(+598.3%) |
| Dec 2018 | $30.00 K | $30.00 K(+2.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2018 | - | $29.40 K(+1.4%) |
| June 2018 | - | $29.00 K(>+9900.0%) |
| Dec 2017 | $0.00(-100.0%) | $0.00(-100.0%) |
| June 2017 | - | $6.67 M(-0.3%) |
| Mar 2017 | - | $6.68 M(+9.4%) |
| Dec 2016 | $6.11 M(>+9900.0%) | $6.11 M(+37.0%) |
| Sept 2016 | - | $4.46 M(>+9900.0%) |
| June 2016 | - | $15.80 K(+1.9%) |
| Mar 2016 | - | $15.50 K(+2.6%) |
| Dec 2015 | $15.10 K(+9.4%) | $15.10 K(+2.0%) |
| Sept 2015 | - | $14.80 K(+2.8%) |
| June 2015 | - | $14.40 K(+1.4%) |
| Mar 2015 | - | $14.20 K(+2.9%) |
| Dec 2014 | $13.80 K(+8.7%) | $13.80 K(+2.2%) |
| Sept 2014 | - | $13.50 K(+2.3%) |
| June 2014 | - | $13.20 K(+2.3%) |
| Mar 2014 | - | $12.90 K(+1.6%) |
| Dec 2013 | $12.70 K(+9.5%) | $12.70 K(+2.4%) |
| Sept 2013 | - | $12.40 K(+2.5%) |
| June 2013 | - | $12.10 K(+2.5%) |
| Mar 2013 | - | $11.80 K(+1.7%) |
| Dec 2012 | $11.60 K | $11.60 K(+13.7%) |
| Sept 2012 | - | $10.20 K(0.0%) |
| June 2012 | - | $10.20 K(+2.0%) |
| Mar 2012 | - | $10.00 K |
FAQ
- What is ADMA Biologics annual short term debt?
- What is the all time high annual short term debt for ADMA Biologics?
- What is ADMA Biologics quarterly short term debt?
- What is the all time high quarterly short term debt for ADMA Biologics?
- What is ADMA Biologics quarterly short term debt year-on-year change?
What is ADMA Biologics annual short term debt?
The current annual short term debt of ADMA is $1.04 M
What is the all time high annual short term debt for ADMA Biologics?
ADMA Biologics all-time high annual short term debt is $6.11 M
What is ADMA Biologics quarterly short term debt?
The current quarterly short term debt of ADMA is $1.19 M
What is the all time high quarterly short term debt for ADMA Biologics?
ADMA Biologics all-time high quarterly short term debt is $6.68 M
What is ADMA Biologics quarterly short term debt year-on-year change?
Over the past year, ADMA quarterly short term debt has changed by +$148.00 K (+14.16%)